Misplaced Pages

Dana Gelb Safran: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 07:40, 26 December 2024 editIdoghor Melody (talk | contribs)Autopatrolled, Event coordinators, Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers32,236 editsm clean up, added orphan, uncategorised tagsTag: AWB← Previous edit Revision as of 08:30, 26 December 2024 edit undoWereSpielChequers (talk | contribs)Bureaucrats, Administrators341,934 edits added Category:American medical academics using HotCatNext edit →
(One intermediate revision by the same user not shown)
Line 31: Line 31:
{{Reflist}} {{Reflist}}



{{Uncategorized|date=December 2024}}

]
]

Revision as of 08:30, 26 December 2024

This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2024)
Dana Gelb Safran
Alma materHarvard T.H. Chan School of Public Health
Wesleyan University
Scientific career
InstitutionsNational Quality Forum
Tufts University School of Medicine
ThesisManaging chronic conditions : patient, provider and system (1992)

Dana Gelb Safran is an American public health expert, president and chief executive officer of the National Quality Forum. She looks to use science to improve the quality, outcomes and affordability of care. She was elected to the National Academy of Medicine in 2024.

Early life and education

Safran studied biology at Wesleyan University. She was a doctoral researcher at the Harvard T.H. Chan School of Public Health. Her PhD explored how patients, providers and healthcare systems can better manage chronic conditions.

Research and career

She spent ten years at the Blue Cross Blue Shield of Massachusetts, where she developed the alternative quality contract. Working with Amazon, Berkshire Hathaway and JPMorgan Chase, Safran developed initiatives to improve the health outcomes and care experiences of patients.

In 2021 Safran was elected president and chief executive officer of the National Quality Forum. The NQF look to evaluate the scientific and clinical merits of healthcare quality measures, and advise Medicare and Medicaid.

In 2024 Safran was elected to the National Academy of Medicine.

Select publications

References

  1. ^ "Dana Gelb Safran | Harvard T.H. Chan School of Public Health". Retrieved 2024-12-25.
  2. ^ "NQF: Dana Gelb Safran". www.qualityforum.org. Retrieved 2024-12-25.
  3. search.worldcat.org https://search.worldcat.org/en/title/83835635. Retrieved 2024-12-25. {{cite web}}: Missing or empty |title= (help)
  4. Radulovic, Jon (2021-07-30). "NQF Board of Directors Appoints Dr. Dana Gelb Safran as New President and CEO". Retrieved 2024-12-25.
  5. Gibbs, Vanessa (2022-02-09). "Take Five Interview with Dana Gelb Safran, ScM and ScD". NJHCQI. Retrieved 2024-12-25.
  6. "NQF: NQF President & CEO Dana Gelb Safran Elected to National Academy of Medicine". www.qualityforum.org. Retrieved 2024-12-25.
Categories: